Continuous and high‐dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study - Concepedia

Concepedia

Publication | Closed Access

Continuous and high‐dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study

37

Citations

14

References

2010

Year

Takashi Taga, Yasuto Shimomura, Yasuo Horikoshi, Atsushi Ogawa, Masaki Itoh, Masahiko Okada, Junichi Ueyama, Takeshi Higa, Arata Watanabe, Hirokazu Kanegane,

Pediatric Blood & Cancer

Abstract

Continuous and high-dose cytarabine combined chemotherapy with reduced intensity would be effective in DS children with AML.

References

	Year	Citations

Page 1